Nissha Co. Ltd. has appointed Brandon Hoffman as CEO and Michael Memminger as chief operating officer (COO)/chief financial officer (CFO) of Nissha Medical Technologies (NMT). These leadership changes reinforce Kyoto, Japan-based Nissha Co.’s commitment to NMT as a core growth platform within the parent entity’s global portfolio.

Hoffman and Memminger bring more than two decades of experience within the Nissha organization, and deep expertise across NMT’s worldwide operations. They will lead the next phase of strategic expansion, operational excellence, and long-term investment.

Under Hoffman’s leadership, NMT has executed a clear growth strategy, integrating strategic acquisitions into the core business model to expand capabilities, accelerate time‑to‑market, and create measurable value for customers worldwide. His approach blends disciplined operational excellence with a forward‑looking investment in transformative healthcare technologies.

Hoffman earned a bachelor of science degree in engineering and an MBA from the State University of New York at Buffalo.

“Our parent company, Nissha, remains steadfast in its support of NMT as a key growth driver, including continued operations at our global headquarters in Buffalo, New York,” Hoffman said. “We have a strong team, a clear strategic direction, and a shared vision to accelerate innovation and deliver exceptional value to our customers worldwide.”

In his dual COO/CFO role, Memminger will provide global direction and oversight of Nissha Medical’s financial activities and fiscal well-being, offering strategic direction and support across M&A efforts and organic growth opportunities.

Memminger has 25 years of progressive experience in corporate financial management and general business management. Prior to this role, he led NMT’s Data Recording and Transactional Media businesses. Before his NMT tenure, Memminger was director of FP&A at Lactalis American Group.

Memminger earned a bachelor of arts degree in international business and world trade from the State University of New York at Buffalo and his MBA in finance at Rochester Institute of Technology.

“I look forward to taking on this expanded role and continuing the successful growth trajectory of NMT,” Memminger stated. “Our focus will remain on operational discipline and leveraging our global capabilities to meet evolving customer needs.”

Nissha Medical Technologies (NMT) provides medical device design and manufacturing services, specializing in patient monitoring and surgical solutions. With manufacturing operations worldwide, NMT advances healthcare through precision engineering and employee development as a global CDMO. Buffalo, N.Y.-headquartered Nissha Medical Technologies is the medical devices business unit and wholly owned subsidiary of Nissha Co. Ltd. , a Japanese publicly held company based in Kyoto, Japan. NMT operates a diverse global manufacturing footprint as a medtech CDMO.